Multimodal Target Validation and Biophysical Control for Axonal Neuro-Regeneration and Isochoric Ex-Vivo Organ Perfusion Across Five Global Biomedical Databases (With Companion Audit Dataset)

AETERNA Clinical & Computational Biology Monograph III + Open-Audit Dataset (2026) Author: Dimitar Stavrev Prodromov (ORCID 0009-0004-8070-1348), AETERNA Technologies EOOD / AETERNA Research Laboratories, Pomorie, Bulgaria (EC PIC 865986222) Authority: 0x41_45_54_45_52_4e_41_5f_4c_4f_47_4f_53_5f_44_49_4d_49_54_41_52_5f_50_52_4f_44_52_4f_4d_56_21 Abstract & Companion Dataset: Formalizes the governing biophysical control equations of AETERNA Module 45 (Becker galvanotactic growth-cone steering, Schlichting 144 Hz CSPG microstreaming thixotropy, and Szegö–Foiaș competitive NgR1/LINGO1 antagonism) and Module 46 (isochoric Clausius–Clapeyron liquidus depression to −21.985 °C at 209.9 MPa, JMAK nucleation suppression χice ≤ 10−7, and CARE Riccati mPTP-locking reperfusion). Cross-audits RTN4R, LINGO1, DNMT3A, and TET2 across GTEx v10, Ensembl GRCh38, OpenTargets Platform, ChEMBL, and ClinicalTrials.gov APIv2 (193 trials). Demonstrates 13.60× (RTN4R) and 171.03× (LINGO1) peripheral nerve selectivity over whole blood with severe gnomAD loss-of-function constraint (o/eLoF = 0.1443 and 0.2950), alongside exact ChEMBL IC50 concordance for Decitabine (393.0 nM) and Vorinostat (120.0–280.0 nM). Accompanied by the machine-verifiable JSON archive AETERNA_PUB3_5DB_MULTIMODAL_AUDIT_DATASET.json. Sovereign License Notice (CC BY-NC-ND 4.0 + PSRL v2.0): Zero source code is disclosed. All biophysical equations, control laws, and the companion dataset schema remain strictly protected under CC BY-NC-ND 4.0 and the Proprietary Sovereign Research License (PSRL v2.0). Upstream public database extracts remain subject to their respective open attribution notices. Commercial exploitation, medical device commercialization, patent/utility model filing, derivative modification, and AI/ML/LLM training (EU AI Act Art. 53(1)(c), Directive (EU) 2019/790 Art. 4(3)) are strictly prohibited worldwide without a bilaterally executed notarized deed. Exclusive Jurisdiction: District Court of Burgas / WIPO Geneva.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-13
DOI
https://doi.org/10.5281/zenodo.24199999
Primary Topic
Nerve injury and regeneration
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multimodal Target Validation and Biophysical Control for Axonal Neuro-Regeneration and Isochoric Ex-Vivo Organ Perfusion Across Five Global Biomedical Databases (With Companion Audit Dataset)

Dimitar Stavrev Prodromov
1 links
Zenodo (CERN European Organization for Nuclear Research)
Nerve injury and regeneration
article

Multimodal Target Validation and Biophysical Control for Axonal Neuro-Regeneration and Isochoric Ex-Vivo Organ Perfusion Across Five Global Biomedical Databases (With Companion Audit Dataset)

Dimitar Stavrev Prodromov
article en

Abstract

AETERNA Clinical & Computational Biology Monograph III + Open-Audit Dataset (2026) Author: Dimitar Stavrev Prodromov (ORCID 0009-0004-8070-1348), AETERNA Technologies EOOD / AETERNA Research Laboratories, Pomorie, Bulgaria (EC PIC 865986222) Authority: 0x41_45_54_45_52_4e_41_5f_4c_4f_47_4f_53_5f_44_49_4d_49_54_41_52_5f_50_52_4f_44_52_4f_4d_56_21 Abstract & Companion Dataset: Formalizes the governing biophysical control equations of AETERNA Module 45 (Becker galvanotactic growth-cone steering, Schlichting 144 Hz CSPG microstreaming thixotropy, and Szegö–Foiaș competitive NgR1/LINGO1 antagonism) and Module 46 (isochoric Clausius–Clapeyron liquidus depression to −21.985 °C at 209.9 MPa, JMAK nucleation suppression χice ≤ 10−7, and CARE Riccati mPTP-locking reperfusion). Cross-audits RTN4R, LINGO1, DNMT3A, and TET2 across GTEx v10, Ensembl GRCh38, OpenTargets Platform, ChEMBL, and ClinicalTrials.gov APIv2 (193 trials). Demonstrates 13.60× (RTN4R) and 171.03× (LINGO1) peripheral nerve selectivity over whole blood with severe gnomAD loss-of-function constraint (o/eLoF = 0.1443 and 0.2950), alongside exact ChEMBL IC50 concordance for Decitabine (393.0 nM) and Vorinostat (120.0–280.0 nM). Accompanied by the machine-verifiable JSON archive AETERNA_PUB3_5DB_MULTIMODAL_AUDIT_DATASET.json. Sovereign License Notice (CC BY-NC-ND 4.0 + PSRL v2.0): Zero source code is disclosed. All biophysical equations, control laws, and the companion dataset schema remain strictly protected under CC BY-NC-ND 4.0 and the Proprietary Sovereign Research License (PSRL v2.0). Upstream public database extracts remain subject to their respective open attribution notices. Commercial exploitation, medical device commercialization, patent/utility model filing, derivative modification, and AI/ML/LLM training (EU AI Act Art. 53(1)(c), Directive (EU) 2019/790 Art. 4(3)) are strictly prohibited worldwide without a bilaterally executed notarized deed. Exclusive Jurisdiction: District Court of Burgas / WIPO Geneva.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Nerve injury and regeneration
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon